108.99
1.36%
-1.50
Jazz Pharmaceuticals plc Azioni (JAZZ) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
4.09%
1,011.93
|
972.14 | 957.32 | 892.81 | 972.12 |
Operating Expenses
|
11.21%
889.44
|
799.75 | 799.68 | 766.76 | 1,235.51 |
Benefits Costs and Expenses |
8.91%
950.41
|
872.62 | 875.53 | 837.71 | 1,312.12 |
Costs And Expenses |
11.21%
889.44
|
799.75 | 799.68 | 766.76 | 1,235.51 |
Operating Income/Loss |
28.94%
122.50
|
172.39 | 157.64 | 126.06 | -263.39 |
Income/Loss Before Equity Method Investments |
38.18%
61.53
|
99.52 | 81.78 | 55.10 | -339.99 |
Income/Loss From Equity Method Investments |
465.87%
-0.461
|
0.126 | -1.669 | -1.005 | -0.773 |
Income/Loss From Continuing Operations Before Tax |
38.18%
61.53
|
99.52 | 81.78 | 55.10 | -339.99 |
Income Tax Expense/Benefit, Deferred |
54.51%
-35.90
|
-78.92 | -79.33 | -66.06 | -145.38 |
Income Tax Expense/Benefit |
29.86%
-33.09
|
-47.18 | -24.32 | -15.32 | -100.04 |
Income/Loss From Continuing Operations After Tax |
35.50%
94.61
|
146.69 | 104.44 | 69.42 | -239.95 |
Net Income/Loss
|
35.87%
94.15
|
146.82 | 104.44 | 69.42 | -240.72 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
100.38%
-0.241
|
63.11 | 63.99 | 63.49 | 0.174 |
Diluted Average Shares |
101.12%
-0.80
|
71.29 | 73.54 | 73.77 | -0.849 |
Basic Earnings Per Share |
35.62%
1.50
|
2.33 | 1.63 | 1.09 | -3.85 |
Diluted Earnings Per Share |
33.18%
1.43
|
2.14 | 1.52 | 1.04 | -3.84 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):